Pacer Advisors Inc. Purchases 1,394 Shares of Fresenius Medical Care Corporation (FMS)

Pacer Advisors Inc. raised its position in Fresenius Medical Care Corporation (NYSE:FMS) by 37.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,105 shares of the company’s stock after acquiring an additional 1,394 shares during the quarter. Pacer Advisors Inc.’s holdings in Fresenius Medical Care were worth $250,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of FMS. UBS Asset Management Americas Inc. lifted its stake in Fresenius Medical Care by 3.6% in the second quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock worth $114,000 after acquiring an additional 81 shares during the last quarter. FFT Wealth Management LLC purchased a new position in Fresenius Medical Care in the second quarter worth approximately $201,000. HPM Partners LLC purchased a new position in Fresenius Medical Care in the second quarter worth approximately $221,000. YorkBridge Wealth Partners LLC lifted its stake in Fresenius Medical Care by 19.4% in the second quarter. YorkBridge Wealth Partners LLC now owns 4,613 shares of the company’s stock worth $222,000 after acquiring an additional 749 shares during the last quarter. Finally, GHP Investment Advisors Inc. purchased a new position in Fresenius Medical Care in the second quarter worth approximately $224,000. Institutional investors own 3.03% of the company’s stock.

A number of research analysts recently issued reports on the stock. DZ Bank reiterated a “buy” rating on shares of Fresenius Medical Care in a research note on Monday, November 13th. Zacks Investment Research downgraded shares of Fresenius Medical Care from a “buy” rating to a “sell” rating in a research note on Wednesday, October 25th. Finally, Royal Bank Of Canada restated a “hold” rating and set a $44.00 price objective on shares of Fresenius Medical Care in a research report on Wednesday, September 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $48.50.

Shares of Fresenius Medical Care Corporation (FMS) opened at $50.95 on Tuesday. The firm has a market cap of $30,638.32, a P/E ratio of 22.31, a PEG ratio of 2.24 and a beta of 0.45. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55. Fresenius Medical Care Corporation has a 12-month low of $39.10 and a 12-month high of $51.54.

WARNING: “Pacer Advisors Inc. Purchases 1,394 Shares of Fresenius Medical Care Corporation (FMS)” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://sportsperspectives.com/2017/12/05/pacer-advisors-inc-purchases-1394-shares-of-fresenius-medical-care-corporation-fms.html.

Fresenius Medical Care Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care Corporation (NYSE:FMS).

Institutional Ownership by Quarter for Fresenius Medical Care (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply